Huntington’s Disease Heroes: A Gratitude Day Feature on Factor-H

There are heroes who walk among us. In the Huntington’s disease (HD) community, some of those heroes are the leaders of Factor-Ha nonprofit organization dedicated to improving the lives of HD families in underserved communities by providing humanitarian aid, education, and advocacy. Huntington’s is an unrelentingly cruel disease that afflicts families with generation after generation of trauma, medical challenges, and overwhelming emotional, financial, and social burdens that can make even the simplest aspects of daily life a struggle.

What could make HD worse? Abject poverty so extreme that families are left utterly resourceless, living in tin-roofed huts with dirt floors without mattresses, electricity, or running water. This is the reality for some of the largest clusters of HD families in the world, located in South America—the same families that contributed to the research that discovered the gene that causes HD. Even still, every scientific advancement that the HD community hopes for and closely scrutinizes likely won’t make its way to these unimaginably vulnerable populations of people without help. That help is Factor-H.

This year, in honor of Gratitude Day—happening today, March 23rd—the HDBuzz editorial team is shining a light on the heroic work being done by Factor-H in an interview with Dr. Ignacio Muñoz-Sanjuán (aka Nacho), President and Founder of Factor-H. Here, we are joining in the spirit of the day, showing gratitude for all that they’re accomplishing for a community to which the global HD families owe so much, while helping to amplify Factor-H’s mission.

The Beginning

HDBuzz: Can you introduce yourself and tell us about your background in Huntington’s disease research and advocacy?

Nacho: I’m a neuroscientist with a specialty in Huntington’s disease. I worked at CHDI Foundation for 15 years as their Vice President for translational biology where my focus became very much concentrated on all aspects targeting huntingtin lowering and then circuit-related therapeutic development. Pretty much anything that related to advancing novel therapeutics for Huntington’s disease, I was responsible for on the biology side.

I came into the field of Huntington’s purely by serendipity. It so happened that one of the science directors of CHDI was a colleague of mine. And back in 2006, they were looking for a head of biology. So, she contacted me, I came down and I decided to venture into this new world of nonprofit foundations doing research. So that’s how I landed in Huntington’s disease.

On the advocacy side, it was a completely unplanned life trajectory. Soon after I started at CHDI, in 2008, I got people affiliated with the organization to come with me to Mexico City, because I had a friend who was the director of the Genomic Medicine Institute in Mexico. I was encouraging people in South America to participate in research studies. And a friend of mine told me, “Nacho, don’t you know the history of Venezuela? We’ve been asking people to participate in a lot of things and they don’t even have any food to eat.” I really didn’t know that aspect of the situation in Venezuela. So, it kind of got me thinking, okay, well, there’s a history here that I don’t understand and I should try to understand. And through that meeting, I got to know some people from Colombia and Venezuela.

So, I spent two summers traveling through Brazil, Colombia, and Venezuela. I was able to see firsthand the magnitude of the problem and what I consider an amazing disconnect between the progress that we were making scientifically with the lack of progress in terms of these people being cared for adequately.

A second thing that happened, after I finished a talk I gave in Brazil, there was an older HD patient from Brazil with his wife. He was in a wheelchair. His disease was pretty advanced, and he did not speak Spanish or English. His wife translated for him when he held my hand and he told me, “Please, please, I know it’s too late for me, but please help my daughter.” At that point, it really made me feel for the first time that the work that we were trying to do was really transgenerational. I might not be able to help many of the other people I would meet directly, but the work I was doing in the advocacy realm could help build a better future for future generations.

So those two things were really impactful for me and it kind of launched me into understanding better the patient perspective by visiting these communities. After I did, I decided I needed to do anything to help them, and that’s how Factor-H was born.

HDBuzz: What’s the story behind the name of Factor-H?

Nacho: I struggled a little bit with a name that could resonate in Spanish and in English. The word “factor” is the same in both languages, number one.

I started thinking about the fact that Huntington’s disease can become the dominant factor in people’s lives. It’s just all encompassing for everybody who is affected and their family members. And I wanted to create an organization where the factor “H” for Huntington’s brought us together, but slowly the H of Huntington’s will be replaced by the H of hope and the H of humanity. So that’s why I call it Factor-H, Huntington’s, Hope, and Humanity.

The idea is hopefully, through science and through our advocacy work, we can support those families so that they develop other factors in their lives that really bring them satisfaction, happiness, stability, and growth.

HDBuzz: What inspired you to start Factor-H, and what is the organization’s primary mission?

Nacho: I have to be honest, at the beginning it was like, “I have no idea what I’m getting myself into. I don’t know what to do. I just saw some horrible things and I want to help.”

So I started organizing parties in my house and collecting clothes and toys. Essentially Factor-H was a project between myself and the other co-founder, who is a clinical geneticist from Buenos Aires, Dr. Claudia Perandones, who now manages the Enroll-HD project in South America, Spain, and Portugal. The two of us decided we needed to do anything that we could think of, but it wasn’t meant to be an organization. It was meant as a project to try to help people. But the more I started going every year, or multiple times a year, people started joining the project. At some point a few years later, I said, “Okay, well, we need to formalize this.”

That’s when we created Factor-H as a nonprofit registered in the United States, six years after I started, in 2018. I think by then the mission was quite clear, which is that we’re using Huntington’s disease to help communities that sit at the interface of neurodegenerative genetic disorders and poverty or conditions of extreme vulnerability. That’s why we focus on the communities that we do, which are the largest clusters of HD families in the world, in South America. They all have very similar characteristics in terms of lack of access to education, to medical care, and suffering from extreme discrimination, and a lot of psychological issues with children.

We took a very holistic approach and we reframed Factor-H as a human rights-based organization, focused on Huntington’s disease, because that’s the disease we know best. Not just taking care of the health implications of having the disease, but rather a broader approach for community development, education, supporting children, supporting caregivers, and essentially filling in for the gaps in access to all kinds of support and care that these communities experience.

We decided to focus on four major pillars, or areas of work. The first one is health, then is youth, community development, and data collection and advocacy. For community development, that includes anything from humanitarian assistance to renovation of homes, to buying adequate bedding for people, to eventually things like adequate bathrooms and septic tanks. A lot of these communities are living with no infrastructure, so to speak, that we’re used to.

For data collection and advocacy, this included establishing our own internal databases where we capture all medical, social, economic, educational information for all the families, so we have maps with the location of every family member that we’ve identified. We know how many kids, what their ages are, what their educational level is. So that’s all included in that area, and that enables us to prioritize the work, but also to begin to influence local entities to support those families when they can. So in many ways we have become the representative voices from those communities, both internationally and locally. Under the advocacy umbrella, we also organize conferences in Latin America, like scientific and medical conferences and other types of educational activities.

Factor-H’s Work & Impact

HDBuzz: Some of what you’re describing are really quite basic things that you’re providing to people. Help us illustrate the level of poverty that we’re talking about and the difficult situations that these people are living in. Can you tell us: What is the typical situation of a family that’s living with Huntington’s disease in Venezuela? What kind of house are they living in? Do they work? Do they have income? What is their life like? Can you paint a picture of what that is like for these families?

Nacho: In Venezuela particularly, we’re working in two main communities. One is located very close to the city of Maracaibo, which is the capital of Zulia state and is the second largest city in the country. There is essentially a small municipality, called San Francisco, of about 4,000 people north of the city, where about 10% of the people will develop Huntington’s disease.

Almost 30 to 40% of all the families in that municipality have a history of HD. Now, we don’t have access to genetic testing in that town, but we can tell you based on the number of patients and the number of individuals at risk, because we’ve characterized every family member there.

The community of Barranquitas, which was very instrumental to the identification of the gene that causes HD, is one of the largest in the world. It’s about 6,000 to 7,000 people, more or less. And again, based on our accounts, anywhere between 10% and 20% of the population will be affected with HD. That community is extraordinarily poor. Overall, about 80 to 90% of all the families we have been supporting live either in poverty or extreme poverty by international standards.

The vast majority don’t have an education. They’re relatively large family structures—five, six, ten children. For many of them, if the mother is affected with HD, it’s fairly typical that they get abandoned by the father, so the kids grow up taking care of a mom and other sick relatives. Their houses, in many cases, lack electricity and running water. They are essentially tin-roofed huts with one room, with maybe a mattress on the floor or a few hammocks, that people have to share. We prioritize helping those extreme cases, but in these communities, the average family typically earns a very minimal income. So, it’s as extreme as you can think about.

HDBuzz: HD in and of itself brings intense, difficult challenges, but to imagine going through that in those conditions of extreme poverty presents incredibly unique challenges. Can you talk about some of those challenges that are specific for that population?

Nacho: The challenges really depend on where these families are living. We have different programs that are geared to Venezuela and Colombia, depending on what we think we can realistically do, and also to the level of support that they might have access to.

In Colombia, a lot of the families are dispersed in rural areas. So, basically, you are in the middle of a rural area with a house that is maybe a mile or two or three miles away from any other house. Then you have patients that have been kept in an isolated room without any type of social visits or interactions for years and years.

In Venezuela, because the communities are so affected, the patients are, in many cases, just walking around the streets and they are living close to family members. They might lack some resources that are available in Colombia, but they don’t lack social interactions. So, the way that the disease impacts quality of life really depends on these elements, which wasn’t clear to me until I started visiting a lot of these families where they may be in a room with no TV, with nothing to do for years at a time, with nobody coming to see them.

That’s part of the reason we established the social agents. They’re essentially social workers, but they’re not formally trained in social work—they go visit people regularly, they sit with them or they wash them. They also act as their representatives when problems arise or the people they visit lack medications or food.

In Venezuela, there are challenges everywhere. When I first went in 2013, there were very good neurology, psychiatry, HD specialists that were taking care of and visiting people. There was access to the genetic test. All of those professionals left the country. So, one of the biggest problems is trying to reconstruct basic neurological and medical services in a landscape where people are continuously leaving the country. We managed, I think, to build an infrastructure in Venezuela that now works and many people are being seen regularly, but it took us a while to figure out how to actually do it.

Access to potable water and adequate food is a big problem for HD patients and children. There’s a lot of parasitic infections because they don’t have septic systems, for example, in Barranquitas. In many cases, families don’t eat more than once a day and the meals are not very nutritious. So, just trying to get regular support on nutritional supplements and adequate food is a problem with the numbers of families that we are supporting. In Venezuela alone, it’s about 600 families with a history of Huntington’s disease that we’re trying to support. At the present moment, I think we have about 205 patients that are clearly symptomatic. It’s probably quite a few more, but we are not calling them HD cases because we don’t have genetic testing.

In Colombia, depending on where people live, we have different sets of problems. The advantage of Colombia is that the healthcare system is operative, even though it’s very challenging for HD families to navigate. I’ll give you an example of one of the programs that I’m really proud of. The Colombian government has included Huntington’s disease in their rare disorders’ legislation, which guarantees access to medications and support like wheelchairs, mattresses, diapers, etc.

The problem is that a lot of the families we represent are poorly educated—many of them don’t know how to read and write, and they certainly don’t understand the rights from a legal perspective or how to access those rights. So, one of the things that we’ve done is to initiate a legal assistance program, where we have a lawyer that works at Factor-H, and now we teamed up with another legal non-governmental organization, and we are aiming to legally support every Huntington’s family that needs help throughout the country so that they know they legally have access to these resources.

For example, there’s a disability legislation that applies to people with Huntington’s disease, but most people don’t know they have those rights that covers a basic income. So, we’ve been doing all the paperwork to ensure that those individuals that don’t have disability status can get it, and therefore we help the affected individual, and also we help their family economically.

If the insurance companies in Colombia do not prescribe medications or wheelchairs or diapers, we present a case to them. We’ve done about 40 or so cases in the last two years, and we’ve won all of them. Now from that point on, the family gets all of the medical assistance the government is obligated to provide. That would never happen in Venezuela, because there is no such system in place, but in Colombia it does. So, a lot of the things that we do are really very much connected with the needs and the context in which these families are living and in what country.

Research & Scientific Collaboration

HDBuzz: In the US, we largely think about HD as a scientific problem. Especially as researchers, often from our view a critical thing is research and getting the research out to the people. But for the areas Factor-H serves, it’s almost an entirely different problem.

Nacho: The way I always think about it is that there are two parallel paths. There’s the path of science and medicine, which is the ultimate solution. We all work in this space and we all know why it’s so important, but it’s very slow. We don’t know when it’s going to happen.

When it happens, how will these families get access to those medications? This is a big area for me in the health domain. But there’s another parallel path, which are the things that we can do today. That really opens up a world of possibilities, because as long as you make people feel good and supported, this can improve their quality of life. That’s the approach that we take with Factor-H as a parallel avenue from scientific work. I think both are needed.

HDBuzz: Can you tell us about how data collection ties in with your work with researchers and clinicians and other stakeholders within this space to try and advance your mission.

Nacho: The only thing we don’t do at Factor-H is research, in the way we understand it— meaning participating in a study monitoring sleep or asking them to give us blood, for example.

The reason is that in Venezuela and in Colombia, and to some extent in Peru, most of the time outside doctors would only go and visit these people to study them. They would come one time, they would tell them all the wonderful things they were doing, they would ask for blood samples or psychological tests or whatever, they leave, and they would publish their paper, and never return.

It took me a number of years to earn the trust of those communities, to get them to feel, “OK, you’re a scientist, but you’re not here because you want something from us. You’re here to help us.” So, from the beginning, we decided that we are collecting this data in order for us to understand and be able to serve them, but not to use this data for medical or scientific research.

HDBuzz: We were wondering about that. How do these families feel about their contributions to research that got us to where we are today, knowing that many advancements, like AMT-130 or brain surgery, may not be accessible to them?

Nacho: That’s part of the work that we hope to do. I’ve already started discussing things with some companies that if their therapies get approved, whether we could institute a free access program for people, especially in Venezuela, assuming that we could.

A gene therapy is not going to be easily accessible in Venezuela, for example, but an oral drug or even ASOs could be. There’s a lot of excellent neurology centers in Latin America. Venezuela is probably the most isolated place right now in terms of access to some of these novel therapies, but for spinal muscular atrophy, many children in Latin America are benefiting from these ASO injections.

I’m more optimistic that as a community, if there are therapies that are approved and we apply some positive pressure and discussions, the number of families is not so large that it makes this a feasible proposition. But certainly, one of my key goals for Factor-H is to mediate that therapies are made available to people there.

All the money raised by Factor-H goes to South America and all the people who are hired by the charity are in South America. They’re all local people. As much as we can, we try to hire social workers for the community, the caregivers that we train are local caregivers. We’re trying to invest as much as we can directly or through education or professional training to focus on local people, because they’re the ones that are going to tell us if something is working or not working.

HDBuzz: Are there any other big unmet medical or social needs that you haven’t mentioned in these underserved regions?

Nacho: Anything that has to do with education is a big problem, especially disease-related education, whether it is the implementation and education around genetic testing and family planning. It’s a big problem in South America in general, both for cultural, religious, and educational barriers.

Education of the local family members as to how to deal with psychiatric symptoms in HD is a big problem. You could have a child or adolescent with juvenile HD. They don’t know what it is. They don’t know how to handle it. So, reinforcing education at all levels of the disease is fundamentally important—that’s laypeople, medical professionals, you name it.

Even though they live with this disease for a generation after generation, there’s still a lot of stigma and really a lack of understanding of the disease and how to deal with the symptoms. The educational aspect that worries me a lot is the education of the kids. We’ve been investing in this for more than 10 years now, which is to create a community of kids who are educated about HD, who have a support network with other HD at risk kids. So that when someone starts having problems, they have somebody to go and talk to.

Public Awareness & Advocacy

HDBuzz: How does Factor-H work to raise awareness about HD in the broader global community?

Nacho: Every four years we organize these very large CHDI-like conferences in South America where we fly in all the world experts. This is not limited to research and clinical trials; we include topics such as occupational therapy, legal rights, and other topics seldom dealt with in scientific conferences. That’s really created a lot of momentum with the local professional communities, and has brought the patient community closer with the professionals working in HD.

We’re still working on ways to more efficiently connect with the worldwide HD community, to let them know about the situation and to know about the work that we do to try to get more support. Certainly we thank you for this article, as HDBuzz is widely read!

HDBuzz: What are some of the largest barriers for increasing the amazing work that Factor-H is doing? Are they primarily financial, or are there other factors?

Nacho: Well, financial always, but I think if more people knew about Factor-H and more people understand that if they give $20, 100% of that donation goes to South America to help somebody. That $20 helps sponsor a child in our programs.

99% of all the philanthropic donations go to HD research because people want a treatment, and that’s not what we do. We also work in relatively small communities, in very poor countries, with a very specific segment of the HD population that not everybody has an interest in. However, it is my desire to make sure that we get more exposure in the sense that more people at a minimum know that these communities exist and how they live. I think if we can all pull together, we can do a lot of things with a relatively small budget.

HDBuzz: What are some of the main misconceptions about HD that you encounter, specifically in the communities that you’re working with?

Nacho: It’s becoming less and less since we’ve been there, but the biggest misconception was that HD was a curse. That there’s a problem with your family and your entire family is being cursed for the rest of life.

In other cases, people who are not from HD families wonder whether the disease is contagious. That really affects a lot of children because they can’t maintain friendships in school the moment they start having symptoms or people know they come from an HD family.

A lot of young people, which I don’t think is different in South America from Europe or North America, but a lot of kids are ashamed of talking about the disease because they feel that maybe their girlfriends or boyfriends, or potential girlfriend or boyfriend, won’t want to date them because they come from an HD family. They fear about their future and feel very alone.

I think in many cases, the fact that it’s genetic and the fact that just because your mom has HD doesn’t mean that you for sure are going to get HD continues to be a misconception that we’re trying to change.

Challenges & Future Goals

HDBuzz: What are the biggest barriers Factor-H faces in its mission, whether logistical, financial, or political?

Nacho: I’m very proud of the infrastructure that we’ve set up. We have clear goals, we have a lot of projects, but we have little money to implement them. In many cases, I am still dissatisfied with the level of healthcare support that we can provide continuously for these family members, especially the people that live in rural areas. It’s very expensive to bring somebody to a clinic every few months, but that’s an aspect that we need to expand. If it was up to me, I would have an entire medical team with maybe a medical van that can facilitate going whenever we need.

The lack of access to genetic testing is a big problem in Venezuela, in my opinion, but it’s not something that we can tackle at this point for many reasons.

If money weren’t an issue, we would do daycare centers for patients and for family members—a place that is safe, that is well conditioned, where they can come and rest and be entertained and where we can organize caregiver support, psychology support, and all the things that we’re doing, but in a properly adequate facility. That would be true in Peru, it would be true in Colombia, and it would be true in Venezuela. All these communities really yearn for a place of their own where they can build community and feel welcome and well cared for.

HDBuzz: How can people outside of Latin America—researchers, advocates, and the general public—support Factor-H’s mission?

Nacho: There’s a lot of things that we can collectively do that don’t involve money, but involve a little bit of time, like working on generating information in a way that is suitable for children or for teenagers about the disease. If someone does a run, they could choose Factor-H as their charity. We’re trying to build an app for caregivers where things are explained in very simple manners, with culturally sensitive language. So, it would be great to have a person that wants to volunteer time to do some coding for app generation, as an example.

All of us that are working on Factor-H all came from the same perspective—we wanted to do something, but we had no idea what to do. If you’re interested in helping our mission, get in touch and we’ll see what we can do together.

Closing Thoughts

HDBuzz: How can Gratitude Day help HD families reflect on their own struggles while also recognizing the even greater challenges faced by those in poverty who have contributed so much to HD research?

Nacho: That’s exactly why we created Gratitude Day. It was Jimmy Pollard’s idea as a way of trying to help raise awareness about what we were trying to do. He came up with the idea of using the day of the publication of the paper that first detailed the genetic cause of HD as a day of gratitude to all the families and to celebrate the collaboration between families and scientists and clinicians.

I think that’s given Factor-H exposure, but it’s also quite beautiful to see—people posting pictures and sending us photographs from all over the world, from India to New Zealand, to Russia, to Turkey, South America, and every year it’s growing. It’s a beautiful way of feeling part of a bigger purpose or a bigger community than just your family and close ones. I think that really helps patients and family members to understand that they’re not alone.

One of the things that I’ve experienced from the beginning was that a lot of people contact me, and they may be in Guatemala or Ecuador or other places, and they really don’t know anybody with Huntington’s disease and they don’t know any professional who knows about the disease. At Factor-H, we’ve become a little bit of a reference for those people. So, in many ways, the more exposure, the more that people will know, the more that we will be able to help.

HDBuzz: Do you have any final messages for HD families around the world that you would like to share?

Nacho: Let’s finish it with Gratitude Day, rather than Factor-H. We came up with Gratitude Day because we wanted to make sure that the immense contributions, particularly from the Venezuelan families, to research and clinical development are not forgotten.

Those extend beyond the identification of the gene. Some of the rating scales, including the UHDRS, were first developed and tested in the field in Venezuela. The first scales that incorporate the psychiatric and cognitive tests, the same. The first evidence of the fact that we have modified genes were identified in Venezuela. The brain samples, the cell lines that are still used in research are from Venezuelans—there’s about 130 different cell lines that are still available that are from the Venezuelan project. So, their contributions were enormous to science.

The second aspect is, if you ask any of the people that went to Venezuela—from Nancy Wexler to Diana Rosas, William Yang, Leslie Thompson, Gill Bates—their careers were influenced tremendously because they went to Venezuela and they were able to interact with those families. So, the sense of community, the sense of purpose, the sense of mission is still reverberating. I just don’t want it to get lost. We’re all getting older and some of the people that went to Venezuela might soon retire. I think the younger generations shouldn’t forget about everything that the Venezuelans contributed and the fact that they’re still there. They need our help, just like we asked for their help when we as a scientific community went there initially.

There are many people with Huntington’s living in conditions that are extraordinarily difficult and they need to feel supported. We have grown into a really powerful community worldwide over the last 20 years, but it’s not really a worldwide community yet. We tend to focus too much on economically developed countries and forget that there are hundreds and thousands of families who are left out of that conversation and I think it’s up to us to reach out to them.

So, for Gratitude Day, I would say try to join us, try to understand why we’re doing what we’re doing, come and join the cause. It’s a wonderful journey and people should just reach out and see where things go from there. Just like I did the first time I went to South America.

To learn more about the inspiring work that Nacho and Factor-H are doing, visit their website. You can stay connected to their mission by giving them a follow on Facebook or Instagram. These heroes are making a profound difference in the lives of the most vulnerable HD families, by bringing hope, dignity, and essential support to those facing unimaginable challenges.

This Gratitude Day, HDBuzz Is Grateful For The Partnership Between HD Families And Scientists

Gratitude Day—Sunday, March 23rd—is a global initiative organized by Factor-H, celebrating the resilience and strength of Huntington’s disease (HD) families, particularly those in underserved communities—the same communities who have historically partnered with the medical and scientific community to advance research. In particular, the families from Venezuela, who did so much to help with our understanding of the disease.

It’s a day to reflect on the power of compassion, solidarity, and support, recognizing the contributions of caregivers, researchers, and advocates working to improve the lives of those affected by HD. For the HD community, Gratitude Day is an opportunity to amplify awareness, and inspire continued action toward a future with better care, resources, and ultimately, effective treatments, which must include families living in conditions of extreme vulnerability.

In honor of Gratitude Day, the HDBuzz editorial team interviewed Dr. Ignacio Muñoz-Sanjuán (aka Nacho), President and Founder of Factor-H, to learn more about their mission, help amplify their message and share in the meaning behind this inspiring day.

Factor-H

HD is a devastating genetic neurodegenerative condition, but today, we’re focusing on the people affected by this disease rather than the science behind it. Specifically, we’re diving into the work of Factor-H, an organization dedicated to supporting HD families in Latin America.

Factor-H is much more than just an organization; it’s a movement. The name itself stands for Huntington’s, Hope, and Humanity, reflecting its mission to shift the dominant factor in these families’ lives from the disease, to hope and the human connection.

Through its four key pillars—health, youth, community development, and data collection and advocacy—Factor-H is making a tangible impact in some of the most underserved HD communities in the world. Nacho describes the work Factor-H is doing as, “using Huntington’s disease to help communities that sit at the interface of neurodegenerative genetic disorders and poverty or conditions of extreme vulnerability.”

The Communities at the Heart of HD Research

Many people are unaware that some of the world’s largest clusters of HD are found in Latin America, particularly in Venezuela, Peru, and Colombia. In these regions, entire families, and sometimes entire villages, are devastated by the disease. In some communities, a staggering 10–20% of the families have a history of HD—a heartbreaking reality.

Adding to the challenge is the extreme poverty that these families face. In Venezuela, many HD families live in tin-roofed huts without running water or electricity. Basic necessities such as food, medicine, and education are often out of reach. Meanwhile, in Colombia, HD families may not experience the same level of economic hardship, but they endure severe isolation, completely cut off from care and resources.

Nacho shares that, “Overall, about 80 to 90% of all the families we have been supporting live either in poverty or extreme poverty by international standards. In many cases, families don’t eat more than once a day and the meals are not very nutritious. So, just trying to get regular support on nutritional supplements and adequate food is a problem with the numbers of families that we are supporting.”

These are the very communities that played a pivotal role in the discovery of the HD gene, published in 1993. Despite this monumental contribution to science, many of these families still lack access to the most basic needs. Factor-H exists to bridge this gap, offering immediate relief while also working toward long-term solutions.

Providing Aid and Creating Lasting Change

Factor-H’s approach is holistic. It recognizes that HD cannot be addressed in isolation from the broader socio-economic challenges these families face. That’s why the organization’s efforts go far beyond medical assistance. Factor-H works closely with essential partners in the various countries where it operates, namely Fundacion Habitat LUZ in Venezuela, the Fundacion Amigos Huntington in Peru, and Fundacion de Antioquia and Universidad Metropolitana in Colombia, among others.

  • Humanitarian aid: Factor-H provides essential supplies such as food, bedding, and medical care to families struggling with extreme poverty.

  • Medical aid: Factor-H promotes, facilitates, and provides access to specialists for symptomatic patients and at-risk children including neurology, pediatric neurology, vaccinations, dental and eye care, speech therapy, among other forms of support.

  • Housing improvements: Many HD families live in unsafe and unstable conditions. Factor-H helps renovate homes to provide safer, more comfortable living environments.

  • Education for children: The organization runs a scholarship program that has helped dozens of children stay in school, giving them hope for a better future despite their families’ struggles with HD.

  • Training caregivers: Local caregivers are trained to support people with HD, ensuring that families have access to knowledgeable and compassionate care.

  • Legal advocacy: Factor-H has successfully helped families in Colombia secure disability benefits and medical assistance, empowering them to navigate systems that might otherwise leave them behind.

The Balance Between Immediate Needs and Research

One of the more complex issues surrounding Factor-H’s work is the balance between direct support and research. While the organization prioritizes immediate needs—understandable given the level of suffering—there is also the question of how these communities might benefit from participation in ethically-designed research projects.

Nacho acknowledges this challenge. Even if new therapies are developed, ensuring accessibility in these regions will be a major hurdle. He has suggested advocating for free access programs, particularly for treatments that could be administered locally, such as oral medications. However, achieving this goal will require major shifts in healthcare policies and infrastructure, and will require the support of companies working to develop novel HD therapeutics.

Battling Stigma and Misconceptions

Beyond the physical and economic struggles, many HD families in Latin America also face deep-seated stigma and misinformation about the disease. This is further potentiated by a lack of education in these areas, often to the level that people can’t read or write.

Nacho highlighted the widespread misconceptions about HD, saying, “People who are not from HD families wonder whether the disease is contagious. That really affects a lot of children because they can’t maintain friendships in school the moment they start having symptoms, or when people know they come from an HD family.” These harmful beliefs contribute to social isolation and further hardship for affected families.

Education and awareness are crucial. Factor-H works to dispel myths and foster greater understanding, not only within HD communities but also in the broader society. This is where global initiatives like Gratitude Day come in.

HD Gratitude Day 2025: Honoring HD Families

March 23rd marks Gratitude Day, an annual event recognizing the contributions of HD families to research while also raising awareness of their ongoing struggles. This day was chosen because it marks the anniversary of the 1993 publication detailing the discovery of the HD gene—a discovery made possible in large part by families in Latin America.

Gratitude Day is not just about reflection; it’s a call to action. The 2025 celebration includes:

  • Kids Lab Day (March 18th): A virtual event connecting children from affected communities with a research lab in France, headed by HD researcher Dr. Christian Neri, inspiring them to engage with science.

  • Candlelight vigils (March 19th & 21st): Families in Venezuela will gather to honor those lost to HD.

  • Pediatric Medical Day (March 20th): A healthcare event dedicated to children in affected communities.

  • Live Stream from Venezuela (Sunday, March 23rd): A global event providing an intimate look into the lives of HD families.

Anyone can participate by joining the live stream—we encourage everyone reading this to pop on to the Zoom and say hi! You can also share messages of support on social media using #HDGratitudeDay, or simply learn more about Factor-H’s work and follow them on Facebook and Instagram.

The Gratitude Day live stream is not just a celebration; it’s an opportunity to challenge misconceptions around HD and shine a light on the strength and the resilience of these communities.

A Model for Sustainable Change

One of the most inspiring aspects of Factor-H’s work is its emphasis on sustainability. The organization is fostering self-sufficiency by empowering local communities. It does this by fully reinvesting into the communities they’re seeking to help—100% of all donations to Factor-H go to supporting these communities in South America.

A key part of this effort is the concept of social agents—local individuals who step up to provide companionship, support, and advocacy within their own communities, and who act as representatives of these families and to facilitate aid. These social agents aren’t necessarily medical professionals; they are trusted members of the community who understand its unique challenges. Their role is invaluable in providing both practical assistance and emotional support to families who might otherwise feel abandoned.

Factor-H is also working to strengthen healthcare infrastructure by training caregivers and advocating for better medical access. Their long-term vision is to create lasting change that extends beyond immediate relief and builds true resilience in HD-affected communities.

A Future of Hope and Humanity

Factor-H is a testament to the power of human connection and compassion. It demonstrates that even in the face of immense challenges, change is possible when people come together with a shared vision of hope and dignity.

For those of us in the HD community and beyond, Factor-H’s work serves as an urgent reminder that scientific progress must go hand-in-hand with social responsibility. While we continue striving for treatments and a cure, we must also ensure that the families who made these advancements possible are not left behind. Nacho said, “We came up with Gratitude Day because we wanted to make sure that the immense contributions, particularly from the Venezuelan families, to research and clinical development are not forgotten.”

As Gratitude Day 2025 approaches, let’s take a moment to honor these families, amplify their voices, and reaffirm our commitment to a future where hope, not hardship, is the defining factor in their lives. So, this Sunday, March 23rd, take a few minutes to extend your hand to the most vulnerable members of the HD community and participate in the hope and humanity that are the primary factors in HD by joining Factor-H’s Gratitude Day live stream.

You can find the Zoom link for Factor-H’s Gratitude Day celebration HERE.

Stay tuned for our full interview with Dr. Ignacio Muñoz-Sanjuán, President and Founder of Factor-H, to be published on Gratitude Day, Sunday, March 23. There, we’ll do a deep dive into the unexpected genesis of an organization born out of the desire to make a positive change, the inspiring work that Factor-H is doing, and the unique issues faced by these incredibly vulnerable populations of HD families. It truly is a profoundly moving and eye-opening read on what we all have to be grateful for—a must read.

The Huntington’s Disease Youth Organization’s World Congress: Supporting Young People Affected by HD

The Huntington’s Disease Youth Organization (HDYO) is an international non-profit dedicated to supporting, educating, and empowering young people up to the age of 35 who are impacted by Huntington’s Disease (HD). Founded in 2012, HDYO provides a safe space for young individuals and their families to access resources, connect with peers, and find professional support. During HDYO’s International Young Adult Congress held in Prague, Czech Republic on March 14-16, HDBuzz was honored to be in attendance, sharing accessible, research-driven insights to empower young people affected by Huntington’s disease.

A Mission Focused on Young People

HDYO’s work revolves around three key areas: support, education, and empowerment. Support is at the heart of the organization’s mission, ensuring that no young person faces HD alone. The organization provides peer-led support groups where young people can share their experiences in a safe environment. Professional support services also help connect individuals with resources in their communities, ensuring they receive the guidance they need.

Education is another crucial aspect of HDYO’s mission. The organization simplifies the complexities of HD through accessible, age-appropriate resources. These materials help young people of all ages and their families understand the disease, learn about its impact, and stay informed about the latest research. By making scientific information more digestible, HDYO bridges the gap between complex research and everyday understanding.

Beyond support and education, HDYO empowers young people to become advocates for themselves and their families. Through personal storytelling, mentorship, and leadership opportunities, the organization helps young individuals develop confidence and a sense of agency. Erasing stigma and fostering resilience within the HD community are fundamental goals of this empowerment work.

What Makes HDYO Unique?

HDYO stands out as the only organization dedicated exclusively to supporting young people affected by HD. Its youth-centric approach ensures that all programs and resources are tailored to the unique challenges faced by young individuals. This includes navigating the decision of whether or not to have a genetic test for HD, care-giving responsibilities for loved ones, especially parents, struggles with social and romantic relationships, as well as challenges to typical education and career paths.

The organization provides a vast array of online and in-person resources, making vital information accessible to young people around the world. These include educational videos, interactive tools for understanding HD, guides for parents and professionals, and virtual and in-person support events. Importantly, HDYO’s website and resources are available in multiple languages, ensuring global accessibility.

A key part of HDYO’s impact comes from its international presence. Through initiatives like the International Representatives program, the organization extends its reach by engaging young volunteers who spread awareness and provide localized support. This model ensures that HDYO’s mission resonates with and benefits communities worldwide.

The HDYO International Young Adult Congress

One of HDYO’s flagship initiatives is the International Young Adult Congress, a gathering designed by and for young people impacted by HD. The 2025 Congress took place last weekend, March 14-16, in Prague, Czech Republic, bringing together young people from across the world for education, connection, and advocacy.

The event’s agenda was structured to address the most pressing concerns facing young individuals in the HD community. Day 1 focused on mental health and community-building, creating a safe space for attendees to share their experiences. Discussions around self-care, grief, and loss helped participants develop coping strategies while interactive sessions encouraged networking.

Day 2 highlighted scientific understanding and personal narratives. Attendees learned about the latest HD research, clinical trials, and treatment developments through accessible presentations. Alongside this, community members shared personal stories about relationship dynamics, communication challenges, and cultural perspectives on HD.

Day 3 provided practical guidance and future planning on topics such as family planning, maintaining a healthy lifestyle, and navigating life after genetic testing. Sessions also explored complex emotional topics like survivor’s guilt and strategies for living at risk. These discussions offered attendees the tools and knowledge to make informed decisions about their futures.

Why Awareness of HDYO Matters

It is essential that young people affected by HD know about HDYO—they are a unique resource for those navigating the challenges of growing up in a family impacted by HD, offering guidance, reassurance, and community support. For many, discovering HDYO provides a sense of belonging and understanding that may be difficult to find elsewhere.

Equally important is ensuring that adults—whether family members, educators, or healthcare professionals—are aware of HDYO’s work. By understanding the resources available, adults can better support young individuals, guiding them to the information and communities that will help them navigate their HD journey.

A Community Built for the Future

HDYO is more than just a resource; it is a movement dedicated to uplifting young people affected by Huntington’s Disease. Through its unique focus on youth, accessible educational materials, and global outreach, the organization plays a critical role in the HD community. Events like the HDYO Congress reinforce the importance of connection and knowledge-sharing, ensuring that no young person has to face HD alone.

Increasing awareness of HDYO’s mission is vital for the next generation. Whether through online resources, peer support, or global events, HDYO continues to provide young people with the tools they need to face the future with confidence. If you know a young person impacted by HD, consider sharing HDYO’s resources with them—your support could make all the difference in helping them feel informed, connected, and empowered.

Listening for Whispers: How a Tiny Protein Could Transform HD Research

A new study bolsters our confidence that neurofilament light (NfL), a protein released by damaged brain cells, could serve as an early warning signal for Huntington’s disease (HD) progression—appearing in the blood many years before symptoms start. Tracking NfL levels may revolutionize HD research by helping predict when symptoms will appear, improving clinical trial design, and opening the door to earlier interventions.

Cracking the Silent Phase

One of the trickiest things about HD is its long silent phase—those years or even decades when someone carries the HD gene but hasn’t yet developed any symptoms. Most people with the gene for HD don’t start noticing changes until their 30s or 40s, but behind the scenes, the disease has been quietly reshaping the brain for years.

Scientists believe that starting treatments early—long before symptoms appear—will have the best shot at slowing or even stopping HD in its tracks. But how can we intervene early if we don’t know exactly when someone will develop symptoms?

What if there was a way to detect the earliest whispers of HD before the disease starts making itself known? That’s been one of the biggest goals in HD research for a long time, and a growing body of evidence suggests that the tiny protein NfL is giving us hope that it might be possible.

What is NfL?

NfL isn’t a new protein on the block, it’s been hanging out in our brains all along. Brain cells release little bits of NfL when they’re damaged or under stress. Think of NfL like a distress signal—a subtle siren going off in the brain, hinting that something isn’t quite right. The more damage happening, the louder that siren gets.

Scientists can measure NfL in the blood with a simple blood test, making it an easy and non-invasive way to peek inside the brain. In fact, clinical trials testing new HD medicines are already using NfL to help measure how well those treatments are working. But what if NfL could tell us even more, like who’s likely to develop symptoms soon, or how quickly HD is progressing? That’s exactly what a new study set out to investigate.

The Gift That Keeps on Giving

This study followed people with HD for an impressive 14 years—long enough to span everything from the rise of Instagram to the return of high-waisted jeans. Back in 2009, a group of volunteers with and without the HD gene signed up for the Cambridge Huntington’s Sleep Study. While the original goal was to track sleep patterns, participants also gave blood samples and completed tests to measure their thinking and movement abilities.

Fast forward to today, and those carefully stored blood samples have become a scientific goldmine. The researchers recently asked participants for permission to test their old blood samples for NfL levels, and 21 gene-positive and 14 gene-negative folks agreed. This kind of long-term follow-up study is incredibly valuable to research, and it shows how one study can keep giving back to the HD community, even years later.

Warning Signs in the Blood

At the start of the study, everyone with the HD gene was still symptom-free. But as the years went on, some people with the HD gene began showing those subtle early signs of HD—small changes in movement or thinking abilities that doctors can measure on a standardized rating scale.

When the researchers looked at the NfL levels in everyone’s blood, they found something remarkable. People who eventually developed symptoms had higher levels of NfL in their blood—even as early as 10 years before any symptoms appeared. This is consistent with a recent study that also found increases in NfL long before symptoms were predicted to appear.

Even more interesting, the speed at which NfL levels rose over time seemed to match how severe symptoms became. It wasn’t just about having more NfL, it was about how fast those levels were climbing.

Imagine standing outside and hearing a faint siren in the distance. The closer it gets, the louder and faster it sounds. That’s what NfL seems to be doing in HD—giving us an early warning of what’s coming and how quickly it’s approaching.

A Window into the Future

If scientists can confirm these findings in larger studies, it could be a game-changer for people with HD. Imagine having a simple blood test that could give you a sense of whether symptoms might start in the next decade, and how quickly the disease might progress. That kind of knowledge could be incredibly empowering.

For some, having that information might help with making decisions about family planning, careers, or finances. Others might prefer to live life as they always have, without that extra layer of information. Both choices are equally valid. What matters is giving people the option to know if they want to.

Supercharging Clinical Trials

NfL could also help solve one of the biggest challenges in HD clinical trials—how much people’s progression rates vary from person to person. Right now, everyone in a trial is compared to the average rate of disease progression, but not everyone follows the average timeline. If someone is naturally a fast progressor, a drug might look like it’s not working even if it’s actually slowing things down.

With NfL, researchers could tailor trials more precisely, identifying the people who are likely to show symptoms sooner and tracking whether the drug is slowing down their NfL rise. This could make trials faster, smaller, and more reliable, helping new treatments reach families sooner.

What’s Next?

Like any good detective story, there are still a few missing clues. Because this study used stored samples from a different research project, not all participants had blood samples at every time point—life happens! The researchers were upfront about these study limitations, and noted that the next step will be to confirm these findings in bigger studies with more consistent data collection.

Still, this study is an exciting first step toward making NfL a powerful tool for tracking HD progression, testing new treatments, and—maybe one day—giving people with the HD gene a clearer view of what the future might hold. The whispers of HD may be faint, but thanks to NfL, we’re starting to hear them a little more clearly.

Wake up call: Sleep is impacted before Huntington’s disease symptoms appear

After getting a poor night’s sleep, anyone would agree that good sleep makes a huge difference in day-to-day life. (Just ask any student who has stayed up all night to cram for a test…or anyone with a newborn baby.) It’s so critical that there’s an awareness week dedicated exclusively to sleep! So during this Sleep Awareness Week, March 9th through 15th, we’re sounding the alarm on sleep issues related to Huntington’s disease (HD) by sharing new research that suggests sleep-related changes may be happening even earlier than we previously thought.

Your brain needs sleep!

Sleep problems are common in people with HD after they begin to experience symptoms. We know that people with HD tend to have less deep sleep and insomnia is really common – in fact, 88% of people with the HD gene report having disturbed sleep. But much less is known about whether sleep issues also occur in people with the gene for HD before symptoms arise.

This is an important area of study, because poor sleep can cause problems with thinking, memory, and mood – already common features of early HD. Plus evidence from other diseases, like Alzheimer’s, has suggested that chronic poor sleep might even accelerate dementia on a biological level.

So if sleep problems were present in people with the gene for HD before other symptoms appear, it makes researchers wonder: If we could intervene and improve sleep, could it lessen thinking, movement, and mood symptoms associated with HD, and perhaps slow down disease progression?

Restless nights start up to 15 years before symptoms

A new study from Monash University in Australia, led by Emily Fitzgerald and colleagues, has recently helped to extend our understanding of how early sleep issues arise in people with the gene for HD.

They recruited a group of 48 adults without the gene for HD alongside a group of 36 people with the gene for HD who were not yet experiencing symptoms. Based on age and CAG repeat length, around a third of the people with the HD gene were predicted to be more than 15 years from developing symptoms, while two-thirds were predicted to be less than 15 years from symptom onset.

They asked study participants to wear a motion sensitive device on their wrist (a bit like a research-grade ‘FitBit’) continuously for two weeks to record their sleep and activity patterns.

They found that sleep in people with the HD gene who were more than 15 years from predicted symptom onset was no different to that of people without the HD gene. However, people with the HD gene who were less than 15 years from symptom onset had markedly disturbed sleep, characterised by broken sleep and more time spent awake during the night. This wasn’t just limited to the study participants who were close to symptom onset; it was even present in those 10-15 years from symptoms.

‘But I carry the HD gene and I sleep fine’

Additionally, they found no relationship between the presence of these sleep problems, and what people with the HD gene reported on subjective sleep questionnaires.

This means that many people with the HD gene who are not yet experiencing other symptoms may be unaware of or underestimate their sleep problems, or that sleep questionnaires fail to capture these sleep problems. So this area may well be a bigger problem than we currently know about.

Don’t turn out the light yet

Before we can say we’ve put sleep issues in HD to bed, it’s important to acknowledge some important caveats related to this research.

Even though the devices used in this study are much more accurate than ‘consumer-grade’ devices like FitBits, it’s important to remember that they only record movement, so their ability to reliably distinguish wakefulness from sleep isn’t 100% accurate. It’s possible, therefore, that some of the movement they picked up was while people were asleep – like turning over in bed.

It’s also important to acknowledge that around a third of the people with the HD gene who were less than 15 years from symptom onset were taking antidepressants, which can impair sleep continuity. When the study team re-analysed the data excluding these individuals, the findings were less extreme.

A high proportion of the people with the HD gene were also women of peri-menopausal age. Women are 40% more prone to insomnia than men (wow!), and on top of that, perimenopause often causes poor sleep, so this may have influenced findings.

Nevertheless, there have been other studies directly recording sleep brainwaves of people with the HD gene who don’t yet have symptoms, including in those not taking antidepressants, that have found similar patterns – suggesting the findings from this recent paper are robust.

Tips for counting sheep

Naturally, the next question is: How could we improve sleep for people with the HD gene who don’t yet have other symptoms?

The answer is NOT to be reaching for traditional ‘sleeping pills’ (things like Valium, Ambien, or drowsy antihistamines), as these induce poor quality sleep, alongside lots of negative daytime side effects like hangover drowsiness, memory problems, and in some cases, dependence.

A new kind of ‘sleeping pills’, known as orexin antagonists, have recently been licensed and appear to induce healthy sleep with a much better side effect profile. However, they are still being studied and have not yet been directly tested in people with HD. Regardless, before any ‘drug-based’ treatment is considered, several other steps are recommended. Our take-homes would be:

  • Take the time to consider your lifestyle factors and how they might be affecting your sleep quality. Things like caffeine, alcohol, nicotine, or lack of daytime activity/light exposure all adversely affect sleep quality, and can be easy to overlook. The same goes for poor ‘sleep hygiene’ – things like sleeping at irregular times, evening screen exposure, or working in the same space that you sleep. Organizations like Sleepstation and The Sleep Charity in the UK and the National Sleep Foundation in the US have great tips on this.

  • Think about having a discussion with your HD clinician or family doctor as to whether you have any symptoms of common sleep disorders – things like ‘restless leg syndrome’ or sleep apnoea (where there are long breathing pauses in sleep). As far as we know, these aren’t more common in HD, but if you did happen to have one of these coincidentally, there are many good treatments available that could improve your sleep quality. So it would be a good idea to get these addressed if they’re present. Likewise, night-time urinary problems, menopausal symptoms, pain, or untreated depression can all really impair sleep – so try to get them addressed with a healthcare professional where present.

  • If insomnia and broken sleep remain an issue after the above steps, consider asking your HD clinician or family doctor if they think a referral for ‘cognitive behavioural therapy for insomnia’ (CBT-I) would be appropriate. This is a highly evidence-based treatment that can really make a difference, and quite a few places now offer it through a digital app, so no need for face-to-face appointments. For instance Sleepio offers CBT-I, which may be covered by your employer’s health care plan in the US and is free through the NHS in the UK.

We still have some way to go before we fully understand the nature and repercussions of sleep problems for people with the HD gene who don’t yet have other symptoms. But if we could hit the snooze button on sleep issues, it’s tempting to dream that this could help keep people with HD healthier for longer. So while work remains, it’s an interesting research area to shine a (night) light on.